Zhixi Li

State Key Laboratory Of Biotherapy
Chengdu, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Exosomes as Drug Carriers in Anti-Cancer Therapy.

Exosomes as Drug Carriers in Anti-Cancer Therapy.

Journal: Frontiers in cell and developmental biology

Published: June 21, 2021

DNA Repair-Based Gene Expression Signature and Distinct Molecular Subtypes for Prediction of Clinical Outcomes in Lung Adenocarcinoma.

DNA Repair-Based Gene Expression Signature and Distinct Molecular Subtypes for Prediction of Clinical Outcomes in Lung Adenocarcinoma.

Journal: Frontiers in medicine

Published: October 10, 2020

PHD2 exerts anti-cancer and anti-inflammatory effects in colon cancer xenografts mice via attenuating NF-κB activity.

PHD2 exerts anti-cancer and anti-inflammatory effects in colon cancer xenografts mice via attenuating NF-κB activity.

Journal: Life sciences

Published: September 14, 2019

CXCR2 is a novel cancer stem-like cell marker for triple-negative breast cancer.

CXCR2 is a novel cancer stem-like cell marker for triple-negative breast cancer.

Journal: OncoTargets and therapy

Published: September 21, 2018

The PI3K and AIB1 interaction is involved in estrogen treated breast cancer cells.

The PI3K and AIB1 interaction is involved in estrogen treated breast cancer cells.

Journal: Cellular and molecular biology (Noisy-le-Grand, France)

Published: April 10, 2018

miR-16 inhibits hyperoxia-induced cell apoptosis in human alveolar epithelial cells.

miR-16 inhibits hyperoxia-induced cell apoptosis in human alveolar epithelial cells.

Journal: Molecular medicine reports

Published: August 02, 2017

MiR-376a suppresses the proliferation and invasion of non-small-cell lung cancer by targeting c-Myc.

MiR-376a suppresses the proliferation and invasion of non-small-cell lung cancer by targeting c-Myc.

Journal: Cell biology international

Published: April 08, 2017

Fibroblast Growth Factor Receptor 1 (FGFR1), Partly Related to Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) and Microvessel Density, is an Independent Prognostic Factor for Non-Small Cell Lung Cancer.

Fibroblast Growth Factor Receptor 1 (FGFR1), Partly Related to Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) and Microvessel Density, is an Independent Prognostic Factor for Non-Small Cell Lung Cancer.

Journal: Medical science monitor : international medical journal of experimental and clinical research

Published: January 16, 2017

Silencing stem cell factor attenuates stemness and inhibits migration of cancer stem cells derived from Lewis lung carcinoma cells.

Silencing stem cell factor attenuates stemness and inhibits migration of cancer stem cells derived from Lewis lung carcinoma cells.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: September 24, 2015

Hypoxia and TGF-β1 lead to endostatin resistance by cooperatively increasing cancer stem cells in A549 transplantation tumors.

Hypoxia and TGF-β1 lead to endostatin resistance by cooperatively increasing cancer stem cells in A549 transplantation tumors.

Journal: Cell & bioscience

Published: July 11, 2015

Quercetin reduces cyclin D1 activity and induces G1 phase arrest in HepG2 cells.

Quercetin reduces cyclin D1 activity and induces G1 phase arrest in HepG2 cells.

Journal: Oncology letters

Published: March 18, 2015

Versican silencing improves the antitumor efficacy of endostatin by alleviating its induced inflammatory and immunosuppressive changes in the tumor microenvironment.

Versican silencing improves the antitumor efficacy of endostatin by alleviating its induced inflammatory and immunosuppressive changes in the tumor microenvironment.

Journal: Oncology reports

Published: January 22, 2015

Showing 1-12 of 15

Last Updated: 09/26/2026